Modified ESHAP as Salvage Chemotherapy for Recurrent or Refractory Non-Hodgkin’s Lymphoma: Results of a Single-Center Study of 32 Patients
暂无分享,去创建一个
E. Kansu | N. Güler | I. Barista | I. Çelik | İ. Güllü | A. Kars | G. Tekuzman | A. Türker | E. Baltalı | M. Altundağ | Y. Özışık | M. Öztürk | Ş. Yalçın